Wolverine Trading, LLC Ligand Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$82.7 - $110.11 $181,940 - $242,242	2,200 New	2,200 $220,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $60 - $645,360	6,000 New	6,000 $513,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $199,479 - $318,276	-2,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $51,076 - $66,340	400 Added 23.53%	2,100 $328,000
Q2 2021 Aug 06, 2021	BUY	$113.03 - $155.64 $192,151 - $264,588	1,700 New	1,700 $230,000
Q1 2020 May 11, 2020	SELL	$63.37 - $107.88 $272,491 - $463,884	-4,300 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$96.94 - $113.59 $29,082 - $34,077	300 Added 7.5%	4,300 $447,000
Q3 2019 Nov 14, 2019	BUY	$86.25 - $120.16 $34,500 - $48,064	400 Added 11.11%	4,000 $396,000
Q2 2019 Aug 20, 2019	SELL	$107.38 - $129.34 $214,760 - $258,680	-2,000 Reduced 35.71%	3,600 $411,000
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $3.65 Million - $4.92 Million	-34,500 Reduced 86.03%	5,600 $704,000
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $5.15 Million - $10.9 Million	40,100 New	40,100 $5.45 Million
Q1 2018 May 15, 2018	SELL	$138.63 - $182.62 $235,671 - $310,454	-1,700 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$128.36 - $147.04 $192,540 - $220,560	-1,500 Reduced 46.88%	1,700 $233,000
Q3 2017 Nov 15, 2017	BUY	$120.91 - $137.94 $386,912 - $441,408	3,200	3,200 $436,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.